![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Bausch + Lomb Bausch + Lomb is a company that develops, manufactures, and markets eye health products. | |
Founding Date | Founding Date 1976 | Founding Date 1980 | Founding Date 1853 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Vaughan, CA HQ Buenos Aires, AR Vienna, AT Minsk, BY Aalst, BE Porto Alegre, BR São Paulo, BR see more |
Employees | Employees 18,077 | Employees 25,200 | Employees 13,500 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) 7.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $5.1b (FY, 2025) |
Net income | Net income N/A | Net income $7.7b (FY, 2025) | Net income ($352m) (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products N/A |

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
Bausch + Lomb is a company that develops, manufactures, and markets eye health products.
View company